BFC Planning’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$125K Sell
2,874
-538
-16% -$24.9K ﹤0.01% 1144
2026
Q2
$146K Buy
3,412
+960
+39% +$52.1K 0.01% 1070
2026
Q1
$154K Buy
2,452
+382
+18% +$30.6K 0.01% 961
2025
Q4
$197K Sell
2,070
-248
-11% -$24.3K 0.01% 872
2025
Q3
$226K Sell
2,318
-74,777
-97% -$7.74M 0.02% 629
2025
Q2
$8.28M Sell
77,095
-928
-1% -$93.9K 0.65% 24
2025
Q1
$7.87M Sell
78,023
-2,550
-3% -$257K 0.69% 20
2024
Q4
$7.2M Sell
80,573
-18
-0% -$1.58K 0.6% 28
2024
Q3
$6.75M Buy
+80,591
New +$6.35M 0.59% 27

Other funds holding BSX

BFC Planning's BSX Position: Q3 2026 in Review

BFC Planning reduced its Boston Scientific (BSX) stake by 16% in Q3 2026, selling an estimated $24.9K and leaving 2,874 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #1144.

BFC Planning first reported a position in BSX in Q3 2024 and has held it in 9 quarters since. The position peaked at $8.28M in Q2 2025. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • BFC Planning held 2,874 shares of Boston Scientific worth $125K as of Q3 2026.
  • BFC Planning sold 538 Boston Scientific shares in Q3 2026, an estimated $24.9K.
  • Boston Scientific made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1144 holding.
  • BFC Planning first reported a position in Boston Scientific in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Boston Scientific position peaked at $8.28M in Q2 2025.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.